HEADER TRANSFERASE 11-OCT-18 6HVJ
TITLE HUMAN PFKFB3 IN COMPLEX WITH A N-ARYL 6-AMINOQUINOXALINE INHIBITOR 3
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 3;
COMPND 3 CHAIN: A;
COMPND 4 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_TAXID: 9606;
SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS KINASE, COMPLEX, METABOLISM, CANCER, TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR K.BANASZAK,H.PAWLIK,A.BIALAS,C.H.FABRITIUS,M.NOWAK
REVDAT 4 15-MAY-24 6HVJ 1 REMARK HETSYN
REVDAT 3 29-JUL-20 6HVJ 1 COMPND REMARK HETNAM SITE
REVDAT 2 16-JAN-19 6HVJ 1 JRNL
REVDAT 1 14-NOV-18 6HVJ 0
JRNL AUTH N.BOUTARD,A.BIALAS,A.SABINIARZ,P.GUZIK,K.BANASZAK,A.BIELA,
JRNL AUTH 2 M.BIEN,A.BUDA,B.BUGAJ,E.CIELUCH,A.CIERPICH,L.DUDEK,
JRNL AUTH 3 H.M.EGGENWEILER,J.FOGT,M.GAIK,A.GONDELA,K.JAKUBIEC,M.JURZAK,
JRNL AUTH 4 A.KITLINSKA,P.KOWALCZYK,M.KUJAWA,K.KWIECINSKA,M.LES,
JRNL AUTH 5 R.LINDEMANN,M.MACIUSZEK,M.MIKULSKI,P.NIEDZIEJKO,A.OBARA,
JRNL AUTH 6 H.PAWLIK,T.RZYMSKI,M.SIEPRAWSKA-LUPA,M.SOWINSKA,
JRNL AUTH 7 J.SZEREMETA-SPISAK,A.STACHOWICZ,M.M.TOMCZYK,K.WIKLIK,
JRNL AUTH 8 L.WLOSZCZAK,S.ZIEMIANSKA,A.ZAREBSKI,K.BRZOZKA,M.NOWAK,
JRNL AUTH 9 C.H.FABRITIUS
JRNL TITL DISCOVERY AND STRUCTURE-ACTIVITY RELATIONSHIPS OF N-ARYL
JRNL TITL 2 6-AMINOQUINOXALINES AS POTENT PFKFB3 KINASE INHIBITORS.
JRNL REF CHEMMEDCHEM V. 14 169 2019
JRNL REFN ESSN 1860-7187
JRNL PMID 30378281
JRNL DOI 10.1002/CMDC.201800569
REMARK 2
REMARK 2 RESOLUTION. 2.28 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.28
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.79
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8
REMARK 3 NUMBER OF REFLECTIONS : 35895
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.202
REMARK 3 R VALUE (WORKING SET) : 0.201
REMARK 3 FREE R VALUE : 0.239
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.000
REMARK 3 FREE R VALUE TEST SET COUNT : 1496
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 3506
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 65
REMARK 3 SOLVENT ATOMS : 118
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 49.43
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.68
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -0.30000
REMARK 3 B22 (A**2) : -0.30000
REMARK 3 B33 (A**2) : 0.96000
REMARK 3 B12 (A**2) : -0.15000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.194
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.177
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.135
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.720
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA
REMARK 3 BOND LENGTH (A) : NULL ; NULL
REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL
REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL
REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL
REMARK 3
REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL
REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL
REMARK 3
REMARK 3 NON-BONDED CONTACT RESTRAINTS.
REMARK 3 SINGLE TORSION (A) : NULL ; NULL
REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL
REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL
REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL
REMARK 3
REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS.
REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL
REMARK 3 PLANAR (DEGREES) : NULL ; NULL
REMARK 3 STAGGERED (DEGREES) : NULL ; NULL
REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 6HVJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-OCT-18.
REMARK 100 THE DEPOSITION ID IS D_1200012334.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 15-NOV-14
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 7.0
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : BESSY
REMARK 200 BEAMLINE : 14.1
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.91841
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : XSCALE
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37392
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.280
REMARK 200 RESOLUTION RANGE LOW (A) : 47.790
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8
REMARK 200 DATA REDUNDANCY : 10.52
REMARK 200 R MERGE (I) : 0.10300
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.0700
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.28
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.42
REMARK 200 COMPLETENESS FOR SHELL (%) : 98.8
REMARK 200 DATA REDUNDANCY IN SHELL : 9.18
REMARK 200 R MERGE FOR SHELL (I) : 0.98200
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.090
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 68.54
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.91
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 2% TACSIMATE, PH 7.0; 5% 2-PROPANOL;
REMARK 280 0.1M IMIDAZOLE; 8% PEG3350, VAPOR DIFFUSION, SITTING DROP,
REMARK 280 TEMPERATURE 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 2 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -Y,X-Y,Z+2/3
REMARK 290 3555 -X+Y,-X,Z+1/3
REMARK 290 4555 -X,-Y,Z+1/2
REMARK 290 5555 Y,-X+Y,Z+1/6
REMARK 290 6555 X-Y,X,Z+5/6
REMARK 290 7555 Y,X,-Z+2/3
REMARK 290 8555 X-Y,-Y,-Z
REMARK 290 9555 -X,-X+Y,-Z+1/3
REMARK 290 10555 -Y,-X,-Z+1/6
REMARK 290 11555 -X+Y,Y,-Z+1/2
REMARK 290 12555 X,X-Y,-Z+5/6
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 169.62533
REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 84.81267
REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 127.21900
REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 42.40633
REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 212.03167
REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 169.62533
REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 84.81267
REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 42.40633
REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 127.21900
REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 212.03167
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 1230 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 20510 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A 0
REMARK 465 PRO A 1
REMARK 465 LEU A 2
REMARK 465 ASP A 17
REMARK 465 ARG A 19
REMARK 465 PRO A 20
REMARK 465 SER A 21
REMARK 465 LEU A 22
REMARK 465 PRO A 23
REMARK 465 ARG A 24
REMARK 465 SER A 25
REMARK 465 CYS A 26
REMARK 465 GLY A 27
REMARK 465 PRO A 28
REMARK 465 LYS A 29
REMARK 465 LEU A 30
REMARK 465 THR A 31
REMARK 465 ASP A 447
REMARK 465 ALA A 448
REMARK 465 LYS A 449
REMARK 465 LYS A 450
REMARK 465 GLY A 451
REMARK 465 PRO A 452
REMARK 465 ASN A 453
REMARK 465 PRO A 454
REMARK 465 LEU A 455
REMARK 465 MET A 456
REMARK 465 ARG A 457
REMARK 465 ARG A 458
REMARK 465 ASN A 459
REMARK 465 SER A 460
REMARK 465 VAL A 461
REMARK 465 THR A 462
REMARK 465 PRO A 463
REMARK 465 LEU A 464
REMARK 465 ALA A 465
REMARK 465 SER A 466
REMARK 465 PRO A 467
REMARK 465 GLU A 468
REMARK 465 PRO A 469
REMARK 465 THR A 470
REMARK 465 LYS A 471
REMARK 465 LYS A 472
REMARK 465 PRO A 473
REMARK 465 ARG A 474
REMARK 465 ILE A 475
REMARK 465 ASN A 476
REMARK 465 SER A 477
REMARK 465 PHE A 478
REMARK 465 GLU A 479
REMARK 465 GLU A 480
REMARK 465 HIS A 481
REMARK 465 VAL A 482
REMARK 465 ALA A 483
REMARK 465 SER A 484
REMARK 465 THR A 485
REMARK 465 SER A 486
REMARK 465 ALA A 487
REMARK 465 ALA A 488
REMARK 465 LEU A 489
REMARK 465 PRO A 490
REMARK 465 SER A 491
REMARK 465 CYS A 492
REMARK 465 LEU A 493
REMARK 465 PRO A 494
REMARK 465 PRO A 495
REMARK 465 GLU A 496
REMARK 465 VAL A 497
REMARK 465 PRO A 498
REMARK 465 THR A 499
REMARK 465 GLN A 500
REMARK 465 LEU A 501
REMARK 465 PRO A 502
REMARK 465 GLY A 503
REMARK 465 GLN A 504
REMARK 465 ASN A 505
REMARK 465 MET A 506
REMARK 465 LYS A 507
REMARK 465 GLY A 508
REMARK 465 SER A 509
REMARK 465 ARG A 510
REMARK 465 SER A 511
REMARK 465 SER A 512
REMARK 465 ALA A 513
REMARK 465 ASP A 514
REMARK 465 SER A 515
REMARK 465 SER A 516
REMARK 465 ARG A 517
REMARK 465 LYS A 518
REMARK 465 HIS A 519
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 LYS A 79 CG CD CE NZ
REMARK 480
REMARK 480 ZERO OCCUPANCY ATOM
REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO
REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS
REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME;
REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 480 M RES C SSEQI ATOMS
REMARK 480 ARG A 8 CG CD NE CZ NH1 NH2
REMARK 480 LYS A 175 CE NZ
REMARK 480 LYS A 204 CG CD CE NZ
REMARK 480 LYS A 291 CD CE NZ
REMARK 480 GLU A 334 CD OE1 OE2
REMARK 480 GLU A 404 CG CD OE1 OE2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 O TYR A 174 O CYS A 177 2.01
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION
REMARK 500 LYS A 291 CG LYS A 291 CD -0.227
REMARK 500 GLU A 404 CB GLU A 404 CG -0.157
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 ARG A 246 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ASN A 127 45.97 39.22
REMARK 500 SER A 179 -118.12 61.32
REMARK 500 ASP A 201 78.70 -118.79
REMARK 500 LYS A 204 -85.54 -131.44
REMARK 500 GLU A 380 -103.35 -105.96
REMARK 500 CYS A 386 -144.03 -144.84
REMARK 500 TYR A 424 10.94 80.19
REMARK 500
REMARK 500 REMARK: NULL
DBREF 6HVJ A 0 519 UNP Q16875 F263_HUMAN 1 520
SEQRES 1 A 520 MET PRO LEU GLU LEU THR GLN SER ARG VAL GLN LYS ILE
SEQRES 2 A 520 TRP VAL PRO VAL ASP HIS ARG PRO SER LEU PRO ARG SER
SEQRES 3 A 520 CYS GLY PRO LYS LEU THR ASN SER PRO THR VAL ILE VAL
SEQRES 4 A 520 MET VAL GLY LEU PRO ALA ARG GLY LYS THR TYR ILE SER
SEQRES 5 A 520 LYS LYS LEU THR ARG TYR LEU ASN TRP ILE GLY VAL PRO
SEQRES 6 A 520 THR LYS VAL PHE ASN VAL GLY GLU TYR ARG ARG GLU ALA
SEQRES 7 A 520 VAL LYS GLN TYR SER SER TYR ASN PHE PHE ARG PRO ASP
SEQRES 8 A 520 ASN GLU GLU ALA MET LYS VAL ARG LYS GLN CYS ALA LEU
SEQRES 9 A 520 ALA ALA LEU ARG ASP VAL LYS SER TYR LEU ALA LYS GLU
SEQRES 10 A 520 GLY GLY GLN ILE ALA VAL PHE ASP ALA THR ASN THR THR
SEQRES 11 A 520 ARG GLU ARG ARG HIS MET ILE LEU HIS PHE ALA LYS GLU
SEQRES 12 A 520 ASN ASP PHE LYS ALA PHE PHE ILE GLU SER VAL CYS ASP
SEQRES 13 A 520 ASP PRO THR VAL VAL ALA SER ASN ILE MET GLU VAL LYS
SEQRES 14 A 520 ILE SER SER PRO ASP TYR LYS ASP CYS ASN SER ALA GLU
SEQRES 15 A 520 ALA MET ASP ASP PHE MET LYS ARG ILE SER CYS TYR GLU
SEQRES 16 A 520 ALA SER TYR GLN PRO LEU ASP PRO ASP LYS CYS ASP ARG
SEQRES 17 A 520 ASP LEU SER LEU ILE LYS VAL ILE ASP VAL GLY ARG ARG
SEQRES 18 A 520 PHE LEU VAL ASN ARG VAL GLN ASP HIS ILE GLN SER ARG
SEQRES 19 A 520 ILE VAL TYR TYR LEU MET ASN ILE HIS VAL GLN PRO ARG
SEQRES 20 A 520 THR ILE TYR LEU CYS ARG HIS GLY GLU ASN GLU HIS ASN
SEQRES 21 A 520 LEU GLN GLY ARG ILE GLY GLY ASP SER GLY LEU SER SER
SEQRES 22 A 520 ARG GLY LYS LYS PHE ALA SER ALA LEU SER LYS PHE VAL
SEQRES 23 A 520 GLU GLU GLN ASN LEU LYS ASP LEU ARG VAL TRP THR SER
SEQRES 24 A 520 GLN LEU LYS SER THR ILE GLN THR ALA GLU ALA LEU ARG
SEQRES 25 A 520 LEU PRO TYR GLU GLN TRP LYS ALA LEU ASN GLU ILE ASP
SEQRES 26 A 520 ALA GLY VAL CYS GLU GLU LEU THR TYR GLU GLU ILE ARG
SEQRES 27 A 520 ASP THR TYR PRO GLU GLU TYR ALA LEU ARG GLU GLN ASP
SEQRES 28 A 520 LYS TYR TYR TYR ARG TYR PRO THR GLY GLU SER TYR GLN
SEQRES 29 A 520 ASP LEU VAL GLN ARG LEU GLU PRO VAL ILE MET GLU LEU
SEQRES 30 A 520 GLU ARG GLN GLU ASN VAL LEU VAL ILE CYS HIS GLN ALA
SEQRES 31 A 520 VAL LEU ARG CYS LEU LEU ALA TYR PHE LEU ASP LYS SER
SEQRES 32 A 520 ALA GLU GLU MET PRO TYR LEU LYS CYS PRO LEU HIS THR
SEQRES 33 A 520 VAL LEU LYS LEU THR PRO VAL ALA TYR GLY CYS ARG VAL
SEQRES 34 A 520 GLU SER ILE TYR LEU ASN VAL GLU SER VAL CYS THR HIS
SEQRES 35 A 520 ARG GLU ARG SER GLU ASP ALA LYS LYS GLY PRO ASN PRO
SEQRES 36 A 520 LEU MET ARG ARG ASN SER VAL THR PRO LEU ALA SER PRO
SEQRES 37 A 520 GLU PRO THR LYS LYS PRO ARG ILE ASN SER PHE GLU GLU
SEQRES 38 A 520 HIS VAL ALA SER THR SER ALA ALA LEU PRO SER CYS LEU
SEQRES 39 A 520 PRO PRO GLU VAL PRO THR GLN LEU PRO GLY GLN ASN MET
SEQRES 40 A 520 LYS GLY SER ARG SER SER ALA ASP SER SER ARG LYS HIS
HET GV8 A 601 31
HET F6P A 602 16
HET PO4 A 603 5
HET FLC A 604 13
HETNAM GV8 8-(3-METHYL-1-BENZOFURAN-5-YL)-~{N}-(4-
HETNAM 2 GV8 METHYLSULFONYLPYRIDIN-3-YL)QUINOXALIN-6-AMINE
HETNAM F6P 6-O-PHOSPHONO-BETA-D-FRUCTOFURANOSE
HETNAM PO4 PHOSPHATE ION
HETNAM FLC CITRATE ANION
HETSYN F6P FRUCTOSE-6-PHOSPHATE; 6-O-PHOSPHONO-BETA-D-FRUCTOSE; 6-
HETSYN 2 F6P O-PHOSPHONO-D-FRUCTOSE; 6-O-PHOSPHONO-FRUCTOSE
FORMUL 2 GV8 C23 H18 N4 O3 S
FORMUL 3 F6P C6 H13 O9 P
FORMUL 4 PO4 O4 P 3-
FORMUL 5 FLC C6 H5 O7 3-
FORMUL 6 HOH *118(H2 O)
HELIX 1 AA1 GLY A 46 ILE A 61 1 16
HELIX 2 AA2 VAL A 70 VAL A 78 1 9
HELIX 3 AA3 SER A 83 ARG A 88 5 6
HELIX 4 AA4 ASN A 91 GLU A 116 1 26
HELIX 5 AA5 THR A 129 ASN A 143 1 15
HELIX 6 AA6 ASP A 156 LYS A 168 1 13
HELIX 7 AA7 SER A 171 LYS A 175 5 5
HELIX 8 AA8 SER A 179 ALA A 195 1 17
HELIX 9 AA9 ASP A 228 ILE A 241 1 14
HELIX 10 AB1 ASN A 256 GLY A 262 1 7
HELIX 11 AB2 SER A 271 ASN A 289 1 19
HELIX 12 AB3 LEU A 300 ALA A 309 1 10
HELIX 13 AB4 LYS A 318 ASN A 321 5 4
HELIX 14 AB5 ALA A 325 GLU A 329 5 5
HELIX 15 AB6 THR A 332 TYR A 340 1 9
HELIX 16 AB7 TYR A 340 ASP A 350 1 11
HELIX 17 AB8 SER A 361 GLN A 379 1 19
HELIX 18 AB9 HIS A 387 LEU A 399 1 13
HELIX 19 AC1 GLU A 405 LEU A 409 5 5
SHEET 1 AA1 2 LEU A 4 GLN A 6 0
SHEET 2 AA1 2 TRP A 13 PRO A 15 -1 O VAL A 14 N THR A 5
SHEET 1 AA2 6 THR A 65 ASN A 69 0
SHEET 2 AA2 6 ILE A 120 ASP A 124 1 O VAL A 122 N PHE A 68
SHEET 3 AA2 6 THR A 35 VAL A 40 1 N ILE A 37 O PHE A 123
SHEET 4 AA2 6 LYS A 146 VAL A 153 1 O LYS A 146 N VAL A 36
SHEET 5 AA2 6 LEU A 211 ILE A 215 1 O VAL A 214 N GLU A 151
SHEET 6 AA2 6 ARG A 220 ASN A 224 -1 O ARG A 220 N ILE A 215
SHEET 1 AA3 6 TYR A 314 GLN A 316 0
SHEET 2 AA3 6 ARG A 294 THR A 297 1 N VAL A 295 O GLU A 315
SHEET 3 AA3 6 VAL A 382 CYS A 386 1 O ILE A 385 N TRP A 296
SHEET 4 AA3 6 ILE A 248 ARG A 252 1 N TYR A 249 O VAL A 382
SHEET 5 AA3 6 THR A 415 VAL A 422 -1 O LEU A 419 N ILE A 248
SHEET 6 AA3 6 GLY A 425 TYR A 432 -1 O GLU A 429 N LYS A 418
CRYST1 103.129 103.129 254.438 90.00 90.00 120.00 P 65 2 2 12
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.009697 0.005598 0.000000 0.00000
SCALE2 0.000000 0.011197 0.000000 0.00000
SCALE3 0.000000 0.000000 0.003930 0.00000